2024-04-16 15:53 | CC:ADK | Diagnos Inc (3) | 0.30 | News Release200 | Diagnos trying to get HC, FDA OK for four AI modules |
2024-04-03 14:31 | CC:ADK | Diagnos Inc (3) | 0.32 | News Release200 | Diagnos grants Couillard option to buy 250,000 shares |
2024-04-02 18:00 | CC:ADK | Diagnos Inc (3) | 0.32 | Private Placement250 | Diagnos 2,064,286-share private placement |
2024-04-02 13:56 | CC:ADK | Diagnos Inc (3) | 0.32 | News Release200 | Diagnos appoints Couillard as director |
2024-03-22 16:23 | CC:ADK | Diagnos Inc (3) | 0.245 | News Release200 | Diagnos closes $182,000 final tranche of financing |
2024-03-04 16:17 | CC:ADK | Diagnos Inc (3) | 0.27 | News Release200 | Diagnos grants option to acquire 250,000 shares |
2024-02-29 14:46 | CC:ADK | Diagnos Inc (3) | 0.28 | News Release200 | Diagnos appoints Braeuel as director |
2024-02-28 12:37 | CC:ADK | Diagnos Inc (3) | 0.285 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-02-28 12:37 | CC:ADK | Diagnos Inc (3) | 0.285 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-02-27 16:27 | CC:ADK | Diagnos Inc (3) | 0.285 | News Release200 | Diagnos closes $396,000 first tranche of financing |
2024-02-23 17:16 | CC:ADK | Diagnos Inc (3) | 0.31 | News Release200 | Diagnos investor Coffin sells 800,000 shares |
2024-01-16 16:16 | CC:ADK | Diagnos Inc (3) | 0.395 | News Release200 | Diagnos appoints Couture as COO, grants option |
2023-12-11 12:31 | CC:ADK | Diagnos Inc (3) | 0.52 | News Release200 | Diagnos signs distribution deal with EssilorLuxottica |
2023-12-11 09:24 | CC:ADK | Diagnos Inc (3) | 0.52 | Resume Trading385 | Diagnos to resume at 6:45 a.m. PT |
2023-12-08 12:25 | CC:ADK | Diagnos Inc (3) | 0.50 | Halt Trading170 | Diagnos halted at 9:20 a.m. PT |
2023-12-07 17:51 | CC:ADK | Diagnos Inc (3) | 0.50 | Private Placement250 | Diagnos 1,828,717-share private placement |
2023-12-04 17:06 | CC:ADK | Diagnos Inc (3) | 0.45 | News Release200 | Diagnos closes $640,050 private placement |
2023-11-28 15:48 | CC:ADK | Diagnos Inc (3) | 0.365 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-28 15:44 | CC:ADK | Diagnos Inc (3) | 0.365 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-10-05 13:24 | CC:ADK | Diagnos Inc (3) | 0.52 | News Release200 | Diagnos rolls out retina analysis in screening program |
2023-08-24 14:16 | CC:ADK | Diagnos Inc (3) | 0.495 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-24 14:15 | CC:ADK | Diagnos Inc (3) | 0.495 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-07-13 16:00 | CC:ADK | Diagnos Inc (3) | 0.54 | SEDAR MD & A815 | SEDAR MD & A |
2023-07-13 15:58 | CC:ADK | Diagnos Inc (3) | 0.54 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-05-26 19:20 | CC:ADK | Diagnos Inc (3) | 0.37 | Private Placement - Debenture255 | Diagnos $865,000 debenture private placement |
2023-05-18 16:41 | CC:ADK | Diagnos Inc (3) | 0.425 | News Release200 | Diagnos closes $865,000 private placement |
2023-05-17 15:07 | CC:ADK | Diagnos Inc (3) | 0.445 | News Release200 | Diagnos, Iris roll out Iris-ai in Quebec |